Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TAK-960 is an orally bioavailable, selective inhibitor of Plks with IC50 values of 0.8, 16.9, and 50.2 nM for Plk1, Plk2, and Plk3, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 58.00 | |
2 mg | In stock | $ 82.00 | |
5 mg | In stock | $ 123.00 | |
10 mg | In stock | $ 173.00 | |
25 mg | In stock | $ 309.00 | |
50 mg | In stock | $ 515.00 | |
100 mg | In stock | $ 747.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 173.00 |
Description | TAK-960 is an orally bioavailable, selective inhibitor of Plks with IC50 values of 0.8, 16.9, and 50.2 nM for Plk1, Plk2, and Plk3, respectively. |
Targets&IC50 | PLK3:50.2 nM, PLK1:0.8 nM , PLK2:16.9 nM |
In vitro | CRC cell lines demonstrated a variable anti-proliferative response to TAK-960 with IC50 values ranging from 0.001 to >?0.75 μmol/L. Anti-proliferative effects were sustained after removal of drug. Following TAK-960 treatment a highly variable accumulation of mitotic (indicating cell cycle arrest) and apoptotic markers was observed. TAK-960 treatment induced G2/M arrest and polyploidy. Six out of the eighteen PDX models responded to single agent TAK-960 therapy (TGII20). The addition of TAK-960 to standard of care chemotherapy resulted in largely additive antitumor effects[1]. |
Cell Research | Fifty-five CRC cell lines and 18 PDX models were exposed to TAK-960 and evaluated for proliferation (IC50) and Tumor Growth Inhibition Index, respectively.?Additionally, 2 KRAS wild type and 2 KRAS mutant PDX models were treated with TAK-960 as single agent or in combination with cetuximab or irinotecan.?TAK-960 mechanism of action was elucidated through immunoblotting and cell cycle analysis[1]. |
Molecular Weight | 561.6 |
Formula | C27H34F3N7O3 |
CAS No. | 1137868-52-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 35 mg/mL (62.32 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TAK-960 1137868-52-0 Cell Cycle/Checkpoint PLK Polo-like Kinase (PLK) TAK960 cell TAK 960 cancer proliferation Inhibitor mitosis leukemia inhibit phosphorylation lines inhibitor